Mariska S. Miranda

Herston Rd
Herston, QLD 4006, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer.

Depleting the Action of EZH2 through PI3K-mTOR Inhibition to Overcome Metastasis and Immunotherapy Resistance in Triple-Negative Breast Cancer.

Journal: Molecular cancer therapeutics

Published: August 14, 2024

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.

Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer.

Journal: NPJ breast cancer

Published: October 09, 2021

Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis.

Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis.

Journal: Cancer research

Published: July 09, 2021

G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.

G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.

Journal: Theranostics

Published: October 23, 2019

Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.

Secreted cellular prion protein binds doxorubicin and correlates with anthracycline resistance in breast cancer.

Journal: JCI insight

Published: March 05, 2019

Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells.

Overexpression of miRNA-25-3p inhibits Notch1 signaling and TGF-β-induced collagen expression in hepatic stellate cells.

Journal: Scientific reports

Published: September 04, 2018

Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.

Multidimensional phenotyping of breast cancer cell lines to guide preclinical research.

Journal: Breast cancer research and treatment

Published: July 23, 2017

RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy.

RAD51 inhibition in triple negative breast cancer cells is challenged by compensatory survival signaling and requires rational combination therapy.

Journal: Oncotarget

Published: December 01, 2015

Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.

Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.

Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine

Published: July 15, 2015

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments.

MEK5-ERK5 pathway associates with poor survival of breast cancer patients after systemic treatments.

Journal: Oncoscience

Published: February 02, 2015

Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma.

Gemcitabine and CHK1 inhibition potentiate EGFR-directed radioimmunotherapy against pancreatic ductal adenocarcinoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: May 20, 2014

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer.

Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer.

Journal: Oncotarget

Published: April 26, 2014

Showing 1-12 of 15

Last Updated: 09/26/2026